Pharmacologic determinants of tobacco dependence

American Journal of Therapeutics

Volumn 3, Issue 5, 1996, Pages 335-341

  Schuh, Leslie M ^a   Schuh, Kory J ^b   Henningfield, Jack E ^a,b  

^a NIDA Addiction Research Center   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dependence; Nicotine; performance; ther apy; tobacco; tolerance; withdrawal

Indexed keywords

NICOTINE;

CONCENTRATION RESPONSE; CONFERENCE PAPER; DEPENDENT PERSONALITY DISORDER; DRUG EFFECT; DRUG TOLERANCE; HUMAN; PRIORITY JOURNAL; REINFORCEMENT; SMOKING CESSATION; TASK PERFORMANCE; WITHDRAWAL SYNDROME;

EID: 0029900335     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199605000-00002     Document Type: Conference Paper

References (42)

1. Henningfield JE, Cohen C, Slade JD: Is nicotine more addictive than cocaine? Br J Addict 1991;86:565-569.
2. McNeill AD: The development of dependence on smoking in children. Br J Addict 1991;86:589-592.
3. Russell MAH: The nicotine addiction trap: a 40-year sentence for four cigarettes. Br J Addict 1990;85:295-300.
4. Langley JN: On the reaction of cells and of nerve endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol 1905;33:374-413.
5. Pomerleau OF, Rosecrans J: Neuroregulatory effects of nicotine. Psychoneuroendocrinology 1989;14:407-423.
6. Domino EF, von Baumgarten AM: Tobacco cigarette smoking and patellar reflex depression. Clin Pharmacol Therap 1969;10:72-78.
7. United States Department of Health and Human Services (US DHHS), Public Health Service: The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General, Government Printing Office, Washington, DC, 1988. [DHHS publication No. (CDC) 88-8406.]
8. Henningfield JE, Keenan RM: Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 1993;61:1-8.
9. Russell MAH: Tobacco smoking and nicotine dependence. In: Research Advances in Alcohol and Drug Problems (Eds. Gibbons RJ, Israel Y, Kalant H, Popham RE, Schmidt W, Smart RG), John Wiley and Sons, New York, 1976, pp. 1-47.
10. Henningfield JE: Behavioral pharmacology of cigarette smoking. In: Advances in Behavioral Pharmacology, Vol. 4 (Eds. Thompson T, Dews PB) Academic Press, New York, 1984, pp. 131-210.
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., rev., American Psychiatric Association, Washington, DC, 1987.
12. Hughes JR, Hatsukami DK: The nicotine withdrawal syndrome: a brief review and update. Int J Smoking Cessation 1992;1:21-26.
13. 3H] nicotine binding sites in human brain. J Neurochem 1988;50: 1243-1247.
14. Corrigall WA: Regulation of intravenous nicotine self-administration - dopamine mechanisms. In: Effects of nicotine on biological Systems. Advances in Pharmacological Sciences (Eds. Adlkofer F, Thurau K), Birkhäuser Verlag, Boston, 1991, pp. 423-432.
15. Fagerström KO, Hurt RD, Säwe U, Tönnesen P: Therapeutic use of nicotine patches: efficacy and safety. J Smoking-Related Dis 1992;3:247-261.
16. Klesges RC, Meyers AW, Klesges LM, LaVasque ME: Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull 1989;106:204-230.
17. Eisen SA, Lyons MJ, Goldberg J, True WR: The impact of cigarette and alcohol consumption on weight and obesity: an analysis of 1911 monozygotic male twin pairs. Arch Intern Med 1993;153:2457-2463.
18. Perkins KA, Epstein LH, Stiller RL, Sexton JE, Debske TD, Jacob RG: Metabolic effects of nicotine after consumption of a meal in smokers and nonsmokers. Am J Clin Nutr 1990;52:228-233.
19. Snyder FR, Henningfield JE: Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology1989;97:17-22.
20. Pickworth WB, Herning RI, Henningfield JE: Spontaneous EEG changes during tobacco abstinence and nicotine substitution. J Pharmacol Exp Ther 1989;251:976-982.
21. Gross J, Stitzer ML: Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology 1989;98:334-341.
22. Foulds J, Stapleton J, Hayward M, Russell MAH, Feyerabend C, Fleming T, Costello J: Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. Arch Fam Med 1993;2:417-423.
23. Heishman SJ, Tayor RC, Henningfield JE: Nicotine and smoking: a review of effects on human performance. Exp Clin Pharmacol 1994;2:345-395.
24. Jarvik ME, Henningfield JE: Pharmacological adjuncts for the treatment of nicotine dependence. In: Nicotine Addiction: Principles and Management (Eds. Slade JD, Orleans CT), Oxford University Press, New York, 1993.
25. Fiore MC: Trends in cigarette smoking in the United States. The epidemiology of tobacco use. Med Clin N Amer 1992;76:289-303.
26. Kozlowski LT, Wilkinson A, Skinner W, Kent C, Frankin T, Pope MA: Comparing tobacco cigarette dependence with other drug dependencies: greater or equal "difficulty quitting" and "urges to use" but less pleasure from cigarettes. J Am Med Assn 1989;261:898-901.
27. United States Department of Health and Human Services (US DHHS), Public Health Service: Preventing Tobacco Use Among Young People: A Report of the Surgeon General, Government Printing Office, Washington, DC, 1994.
28. Benowitz NL: Pharmacokinetics considerations in understanding nicotine dependence. In: 1990 The Biology of Nicotine Dependence (Ciba Foundation Symposium 152) John Wiley and Sons, Chichester 1990, pp. 186-209.
29. Ross HD, Chan KH, Piraino AJ, John VA: Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers. Pharm Res 1991;8:385-388.
30. Benowitz NL, Jacob P, Denaro C, Jenkins R: Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Therap 1991;49:270-277.
31. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED: Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 1993;33:23-29.
32. Benowitz NL, Kuyt F, Jacob P: Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clin Pharmacol Therap 1984;36:74-81.
33. Henningfield JE, London ED, Benowitz NL: Arterialvenous differences in plasma concentrations of nicotine after cigarette smoking. J Am Med Assn 1990;263:2049-2050.
34. Cummings SR, Richard RJ: Optimum cutoff points for biochemical validation of smoking status. Am J Public Health 1988;78:574-575.
35. Jarvis MJ: Application of biochemical intake markers to passive smoking measurement and risk estimation. Mutat Res 1989;222:101-110.
36. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y: Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987;77: 1435-1438.
37. Benowitz NL, Jacob P, Kozlowski LT, Yu L: Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med 1986;315:1310-1313.
38. Benowitz NL, Henningfield JE: Establishing a nicotine threshold for addiction: implications for tobacco regulation. N Engl J Med 1994;331:123-125.
39. Henningfield JE, Kozlowski LT, Benowitz NL: A proposal to develop meaningful labeling for cigarettes. J Am Med Assn 1994;272:312-314.
40. Kottke TE, Brekke ML, Solberg LI, Hughes JR: A randomized trial to increase smoking intervention by physicians: doctors helping smokers. Round I. J Am Med Assn 1989;261:2101-2106.
41. Hughes JR, Gulliver SB, Fenwick JW, Valliere WA, Cruser K, Pepper S, Shea P, Solomon LJ, Flynn BJ: Smoking cessation among self-quitters. Health Psychol 1992;11:331-334.
42. Doll R, Peto R, Wheatley K, Gray R, Sutherland I: Mortality in relation to smoking: 40 years' observation on male British doctors. Br Med J 1994;309:901-910.